Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alexandre

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Internal Medicine|October 22, 2016
Long delay to onset of ACE inhibitors-induced cough: Reason of difficult diagnosis in primary care?X Humbert, J Alexandre, M Sassier, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2008
An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patientsJ Trédaniel, C Becht, M Bekradda, et al.
L'Encephale|July 27, 2021
[Antidepressive agents and hypertension: A case/no-case study in French pharmacovigilance database]A Hofferer, C Dolladille, B Chretien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2010
Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experienceJ Alexandre, I Ray-Coquard, F Selle, et al.
International Journal of Cancer|November 11, 2010
Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted formC Mongaret, J Alexandre, A Thomas-Schoemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2011
Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO)A Lortholary, R Largillier, B Weber, et al.
Bulletin Du Cancer|February 16, 2000
[High-dose chemotherapy in ovarian adenocarcinoma]J P Lotz, C Lhommé, P Pautier, et al.
Arquivos Brasileiros De Cardiologia|November 17, 1998
[Apical hypertrophic cardiomyopathy associated with coronary artery disease]F M Albanesi Filho, J S Lopes, J D Aron Diamant, et al.
Clinical Pharmacology and Therapeutics|June 13, 2006
Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphismsA Tran, V Jullien, J Alexandre, et al.
Cancer Chemotherapy and Pharmacology|May 17, 2017
Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicityM Bretagne, A Jouinot, J P Durand, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Internal Medicine|October 22, 2016
Long delay to onset of ACE inhibitors-induced cough: Reason of difficult diagnosis in primary care?X Humbert, J Alexandre, M Sassier, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2008
An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patientsJ Trédaniel, C Becht, M Bekradda, et al.
L'Encephale|July 27, 2021
[Antidepressive agents and hypertension: A case/no-case study in French pharmacovigilance database]A Hofferer, C Dolladille, B Chretien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2010
Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experienceJ Alexandre, I Ray-Coquard, F Selle, et al.
International Journal of Cancer|November 11, 2010
Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted formC Mongaret, J Alexandre, A Thomas-Schoemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2011
Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO)A Lortholary, R Largillier, B Weber, et al.
Bulletin Du Cancer|February 16, 2000
[High-dose chemotherapy in ovarian adenocarcinoma]J P Lotz, C Lhommé, P Pautier, et al.
Arquivos Brasileiros De Cardiologia|November 17, 1998
[Apical hypertrophic cardiomyopathy associated with coronary artery disease]F M Albanesi Filho, J S Lopes, J D Aron Diamant, et al.
Clinical Pharmacology and Therapeutics|June 13, 2006
Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphismsA Tran, V Jullien, J Alexandre, et al.
Cancer Chemotherapy and Pharmacology|May 17, 2017
Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicityM Bretagne, A Jouinot, J P Durand, et al.
Pageof 11